133 related articles for article (PubMed ID: 37580878)
1. The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study.
Glickman D; Dalessio S; Raup-Konsavage WM; Vrana KE; Coates MD
Inflamm Bowel Dis; 2024 Jul; 30(7):1055-1061. PubMed ID: 37580878
[TBL] [Abstract][Full Text] [Related]
2. Cannabis use amongst patients with inflammatory bowel disease.
Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
[TBL] [Abstract][Full Text] [Related]
3. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
[TBL] [Abstract][Full Text] [Related]
4. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study.
Nugent Z; Singh H; Targownik LE; Strome T; Snider C; Bernstein CN
Inflamm Bowel Dis; 2016 Dec; 22(12):2907-2916. PubMed ID: 27846193
[TBL] [Abstract][Full Text] [Related]
6. Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.
Huh G; Yoon H; Choi YJ; Shin CM; Park YS; Kim N; Lee DH; Kim JS
PLoS One; 2019; 14(1):e0210703. PubMed ID: 30650133
[TBL] [Abstract][Full Text] [Related]
7. Home Infliximab Infusions Are Associated With Suboptimal Outcomes Without Cost Savings in Inflammatory Bowel Diseases.
Giese-Kim N; Wu M; Dehghan M; Sceats LA; Park KT
Am J Gastroenterol; 2020 Oct; 115(10):1698-1706. PubMed ID: 32701731
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data.
Long GH; Tatro AR; Oh YS; Reddy SR; Ananthakrishnan AN
Adv Ther; 2019 Nov; 36(11):3079-3095. PubMed ID: 31562607
[TBL] [Abstract][Full Text] [Related]
9. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Sheehan JL; Jacob J; Berinstein EM; Greene-Higgs L; Steiner CA; Berry SK; Shannon C; Cohen-Mekelburg SA; Higgins PDR; Berinstein JA
Inflamm Bowel Dis; 2022 Dec; 28(12):1904-1914. PubMed ID: 35230420
[TBL] [Abstract][Full Text] [Related]
10. Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse.
Hansen TM; Sabourin BC; Oketola B; Bernstein CN; Singh H; Targownik LE
Inflamm Bowel Dis; 2020 Aug; 26(9):1401-1406. PubMed ID: 31725152
[TBL] [Abstract][Full Text] [Related]
11. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
12. Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.
Ballou S; Hirsch W; Singh P; Rangan V; Nee J; Iturrino J; Sommers T; Zubiago J; Sengupta N; Bollom A; Jones M; Moss AC; Flier SN; Cheifetz AS; Lembo A
Aliment Pharmacol Ther; 2018 Apr; 47(7):913-921. PubMed ID: 29411411
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study.
Chen G; Lissoos T; Dieyi C; Null KD
Inflamm Bowel Dis; 2021 Jul; 27(8):1177-1183. PubMed ID: 33043982
[TBL] [Abstract][Full Text] [Related]
14. Associations between prior healthcare use, time to diagnosis, and clinical outcomes in inflammatory bowel disease: a nationally representative population-based cohort study.
Jayasooriya N; Saxena S; Blackwell J; Bottle A; Creese H; Petersen I; Pollok RCG;
BMJ Open Gastroenterol; 2024 May; 11(1):. PubMed ID: 38802264
[TBL] [Abstract][Full Text] [Related]
15. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.
Storr M; Devlin S; Kaplan GG; Panaccione R; Andrews CN
Inflamm Bowel Dis; 2014 Mar; 20(3):472-80. PubMed ID: 24407485
[TBL] [Abstract][Full Text] [Related]
16. Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids.
Noureldin M; Higgins PDR; Govani SM; Cohen-Mekelburg S; Kenney BC; Stidham RW; Waljee JF; Waljee AK
Aliment Pharmacol Ther; 2019 Jan; 49(1):74-83. PubMed ID: 30430615
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort.
Jeuring SFG; Biemans VBC; van den Heuvel TRA; Zeegers MP; Hameeteman WH; Romberg-Camps MJL; Oostenbrug LE; Masclee AAM; Jonkers DMAE; Pierik MJ
Am J Gastroenterol; 2018 Mar; 113(3):384-395. PubMed ID: 29317770
[TBL] [Abstract][Full Text] [Related]
18. Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease.
Lewis JD; Scott FI; Brensinger CM; Roy JA; Osterman MT; Mamtani R; Bewtra M; Chen L; Yun H; Xie F; Curtis JR
Am J Gastroenterol; 2018 Mar; 113(3):405-417. PubMed ID: 29336432
[TBL] [Abstract][Full Text] [Related]
19. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
20. Impact of antitumour necrosis factor therapy on surgery in inflammatory bowel disease: a population-based study.
Hawthorne AB; Arms-Williams B; Cannings-John R; Pollok RCG; Berry A; Harborne P; Trivedi A
BMJ Open Gastroenterol; 2024 May; 11(1):. PubMed ID: 38777566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
